Skip to main content

Saturn Medic

Hypersplenism

Clinical Subject Page

Hypersplenism

Hypersplenism is a condition in which an overactive spleen excessively sequesters and destroys blood cells, leading to one or more cytopenias (anemia, leukopenia, and/or thrombocytopenia). It is usually secondary to splenomegaly or another underlying disorder.

Also called

Overactive spleen

ICD-10

D73.1

Specialty

Gastroenterology

Onset

Chronic

Reviewed

July 2026

On This Page

Overview

  • Hypersplenism occurs when the spleen becomes enlarged or overactive and traps excessive numbers of red blood cells, white blood cells, and platelets. This results in cytopenias despite normal or increased bone marrow production. Patients may present with fatigue, recurrent infections, easy bruising, or bleeding. Diagnosis is based on cytopenias, splenomegaly, and exclusion of other causes. Treatment focuses on the underlying condition, while splenectomy is reserved for selected cases.

Etiology & Risk Factors

Common Causes

Portal Hypertension

  • Liver cirrhosis (most common)

  • Portal vein thrombosis

  • Splenic vein thrombosis

Hematological Disorders

  • Hemolytic anemia

  • Thalassemia

  • Sickle cell disease

  • Hereditary spherocytosis

  • Myelofibrosis

  • Polycythemia vera

Infections

  • Infectious mononucleosis

  • Malaria

  • Tuberculosis

  • HIV

  • Visceral leishmaniasis

Malignancies

  • Leukemia

  • Lymphoma

  • Myeloproliferative neoplasms

Autoimmune and Inflammatory Diseases

  • Systemic lupus erythematosus

  • Rheumatoid arthritis (Felty syndrome)

  • Sarcoidosis

Storage Diseases

  • Gaucher disease

  • Niemann-Pick disease

Risk Factors

  • Chronic liver disease

  • Portal hypertension

  • Splenomegaly

  • Chronic infections

  • Hematological disorders

  • Hematological malignancies

  • Autoimmune diseases

Pathophysiology

Underlying disease causes splenic enlargement or hyperactivity, leading to increased pooling and destruction of blood cells within the spleen. Although the bone marrow usually maintains normal or increased production, excessive sequestration shortens the lifespan of red blood cells, white blood cells, and platelets, resulting in anemia, leukopenia, thrombocytopenia, or pancytopenia.

Clinical Presentation

    • Symptoms

      • Fatigue

      • Weakness

      • Easy bruising

      • Easy bleeding

      • Recurrent infections

      • Left upper-quadrant discomfort

      • Early satiety

      • Abdominal fullness

      Signs

      • Splenomegaly

      • Pallor

      • Petechiae

      • Ecchymosis

      • Hepatomegaly (if portal hypertension)

      • Signs of chronic liver disease

History Taking

  • Ask about:

    • Fatigue or weakness
    • Easy bruising or bleeding
    • Recurrent infections
    • Left upper-quadrant pain or fullness
    • Early satiety
    • History of liver disease
    • Alcohol use
    • Viral hepatitis
    • Previous blood disorders
    • Autoimmune disease

Physical Examination

General Examination

Look for:

  • Pallor

  • Petechiae

  • Ecchymosis

  • Fever

  • Lymphadenopathy

  • Jaundice

Abdominal Examination

Assess for:

  • Splenomegaly

  • Hepatomegaly

  • Ascites

  • Abdominal tenderness

  • Signs of portal hypertension

Other Examination

Look for:

  • Stigmata of chronic liver disease

  • Lymph node enlargement

  • Features of hematological malignancy

  • Autoimmune manifestations

Investigations

  • Laboratory Tests

    • Complete blood count

    • Peripheral blood smear

    • Reticulocyte count

    • Liver function tests

    • Renal function

    • Coagulation profile

    • Lactate dehydrogenase

    • Bilirubin

    • Haptoglobin

    • Viral serology

    • Autoimmune screen

    Bone Marrow Examination

    Usually shows normal or hypercellular marrow, confirming that cytopenias result from peripheral sequestration rather than bone marrow failure.

    Imaging

    Abdominal Ultrasound

    • Confirms splenomegaly

    • Assesses liver disease

    • Detects portal hypertension

    CT Abdomen

    • Evaluates splenic size

    • Identifies underlying malignancy

    • Detects focal splenic lesions

    Additional Tests

    • Bone marrow biopsy (when indicated)

    • JAK2 mutation testing

    • Flow cytometry

    • Hemoglobin electrophoresis

Diagnosis

  • Diagnosis is based on:

    • Splenomegaly
    • One or more peripheral cytopenias
    • Normal or hypercellular bone marrow
    • Improvement after treatment of the underlying cause or splenectomy
    • Exclusion of primary bone marrow disorders
Home / Home / Clinical Cases / Gastrointestinal System Clinical Cases / Hypersplenism

Related Topics

Management

    • Treat the Underlying Cause

      • Manage liver cirrhosis or portal hypertension

      • Treat infections

      • Treat autoimmune diseases

      • Manage hematological disorders

      • Treat malignancy

      Supportive Treatment

      • Blood transfusion if required

      • Platelet transfusion for severe thrombocytopenia

      • Infection management

      • Nutritional support

      Splenectomy

      Consider only in selected patients with:

      • Severe symptomatic hypersplenism

      • Recurrent transfusion requirement

      • Severe thrombocytopenia or neutropenia

      • Failure of medical treatment

      • Selected hematological disorders

      Splenic Artery Embolization

      May be considered in patients who are poor surgical candidates.

Complications

  • Severe anemia
  • Recurrent infections
  • Severe thrombocytopenia
  • Spontaneous bleeding
  • Pancytopenia
  • Splenic rupture (rare)
  • Complications of the underlying disease

Prognosis

  • The prognosis depends on the underlying cause. Cytopenias often improve after successful treatment of the primary disease or splenectomy. Patients with advanced cirrhosis or hematological malignancies generally have a poorer prognosis.

Key Points / Clinical Pearls

  • Hypersplenism is an overactive spleen causing excessive destruction of blood cells.
  • It usually occurs secondary to splenomegaly.
  • Portal hypertension due to liver cirrhosis is the most common cause.
  • Patients develop anemia, leukopenia, thrombocytopenia, or pancytopenia.
  • Bone marrow is usually normal or hypercellular.
  • Treatment focuses on the underlying disease.
  • Splenectomy is reserved for selected symptomatic patients.
  • Vaccination is essential before elective splenectomy.
  •  
  • Chapman J, Goyal A, Azevedo AM. National Center for Biotechnology Information (NIH). Splenomegaly, StatPearls.
  • Merck Manual Professional Edition. Hypersplenism.
  • Zhang M, Wang Y, Zhang X, et al. Impact of Total Splenectomy on Peripheral Lymphocytes and Their Subsets in Patients With Hypersplenism Associated With Cirrhotic Portal Hypertension. PMC8553769.
  • Dameshek W. Hypersplenism. Bull N Y Acad Med. 1955;31:113-136.
  • National Center for Biotechnology Information (NIH). Splenectomy for Hematological Disorders, Surgical Treatment.